McIlrath & Eck’s PetMed Express PETS Stock Holding History

McIlrath & Eck’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-85	Closed	-$3K	–	773
2020 Q4	$3K	Hold	85	–	–	﹤0.01%	595
2020 Q3	$3K	Hold	85	–	–	﹤0.01%	558
2020 Q2	$3K	Buy	+85	New	+$2.95K	﹤0.01%	554

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

McIlrath & Eck's PETS Position: Q1 2021 in Review

McIlrath & Eck sold out of PetMed Express (PETS) in Q1 2021, closing a stake of 85 shares — an estimated $3K sold.

McIlrath & Eck first reported a position in PETS in Q2 2020 and held it in 3 quarters. The position peaked at $3K in Q4 2020. 205 funds tracked by Wall St. Rank hold PETS as of Q1 2021.

McIlrath & Eck reported no remaining PetMed Express position as of Q1 2021 after selling out during the quarter.
McIlrath & Eck sold 85 PetMed Express shares in Q1 2021, an estimated $3K.
McIlrath & Eck first reported a position in PetMed Express in Q2 2020 and held it in 3 quarters.
McIlrath & Eck's PetMed Express position peaked at $3K in Q4 2020.
205 funds tracked by Wall St. Rank held PetMed Express as of Q1 2021.

Based on McIlrath & Eck's 13F filing for Q1 2021, filed 12 May 2021.